Pheochromocytoma and paraganglioma in cyanotic congenital heart disease
- PMID: 25581599
- PMCID: PMC4399286
- DOI: 10.1210/jc.2014-3863
Pheochromocytoma and paraganglioma in cyanotic congenital heart disease
Abstract
Context: Aberrant cellular oxygen sensing is a leading theory for development of pheochromocytoma (PHEO) and paraganglioma (PGL).
Objective: The objective of the study was to test the hypothesis that chronic hypoxia in patients with cyanotic congenital heart disease (CCHD) increases the risk for PHEO-PGL.
Design/setting/participants: We investigated the association between CCHD and PHEO-PGL with two complementary studies: study 1) an international consortium was established to identify congenital heart disease (CHD) patients with a PHEO-PGL diagnosis confirmed by pathology or biochemistry and imaging; study 2) the 2000-2009 Nationwide Inpatient Survey, a nationally representative discharge database, was used to determine population-based cross-sectional PHEO-PGL frequency in hospitalized CCHD patients compared with noncyanotic CHD and those without CHD using multivariable logistic regression adjusted for age, sex, and genetic PHEO-PGL syndromes.
Results: In study 1, we identified 20 PHEO-PGL cases, of which 18 had CCHD. Most presented with cardiovascular or psychiatric symptoms. Median cyanosis duration for the CCHD PHEO-PGL cases was 20 years (range 1-57 y). Cases were young at diagnosis (median 31.5 y, range 15-57 y) and 7 of 18 had multiple tumors (two bilateral PHEO; six multifocal or recurrent PGL), whereas 11 had single tumors (seven PHEO; four PGL). PGLs were abdominal (13 of 17) or head/neck (4 of 17). Cases displayed a noradrenergic biochemical phenotype similar to reported hypoxia-related PHEO-PGL genetic syndromes but without clinical signs of such syndromes. In study 2, hospitalized CCHD patients had an increased likelihood of PHEO-PGL (adjusted odds ratio 6.0, 95% confidence interval 2.6-13.7, P < .0001) compared with those without CHD; patients with noncyanotic CHD had no increased risk (odds ratio 0.9, P = .48).
Conclusions: There is a strong link between CCHD and PHEO-PGL. Whether these rare diseases coassociate due to hypoxic stress, common genetic or developmental factors, or some combination requires further investigation.
Similar articles
-
Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.Clin Endocrinol (Oxf). 2017 Jan;86(1):141-149. doi: 10.1111/cen.13163. Epub 2016 Aug 26. Clin Endocrinol (Oxf). 2017. PMID: 27460956
-
Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review.Front Endocrinol (Lausanne). 2018 Apr 17;9:165. doi: 10.3389/fendo.2018.00165. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29719528 Free PMC article.
-
Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases.Clin Exp Med. 2022 Aug;22(3):359-370. doi: 10.1007/s10238-021-00763-3. Epub 2021 Sep 30. Clin Exp Med. 2022. PMID: 34591219 Review.
-
Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.Endocrine. 2022 Dec;78(3):580-586. doi: 10.1007/s12020-022-03205-6. Epub 2022 Oct 4. Endocrine. 2022. PMID: 36194345
-
A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.J Clin Endocrinol Metab. 2010 May;95(5):2023-37. doi: 10.1210/jc.2009-2830. Epub 2010 Mar 9. J Clin Endocrinol Metab. 2010. PMID: 20215394 Review.
Cited by
-
Paragangliomas and syringomyelia in Tetralogy of Fallot-A case report and literature review.Clin Case Rep. 2024 Oct 16;12(10):e9448. doi: 10.1002/ccr3.9448. eCollection 2024 Oct. Clin Case Rep. 2024. PMID: 39416598 Free PMC article.
-
Outcomes after cancer diagnosis in children and adult patients with congenital heart disease in Sweden: a registry-based cohort study.BMJ Open. 2024 Apr 17;14(4):e083237. doi: 10.1136/bmjopen-2023-083237. BMJ Open. 2024. PMID: 38631823 Free PMC article.
-
Clinical Progression of a Paraganglioma Over Many Years in a Man With Congenital Heart Disease.AACE Clin Case Rep. 2023 Sep 26;9(6):193-196. doi: 10.1016/j.aace.2023.09.003. eCollection 2023 Nov-Dec. AACE Clin Case Rep. 2023. PMID: 38045797 Free PMC article.
-
Successful perioperative management of pheochromocytoma in a patient with Fontan circulation.J Cardiol Cases. 2023 Jun 17;28(2):75-78. doi: 10.1016/j.jccase.2023.04.015. eCollection 2023 Aug. J Cardiol Cases. 2023. PMID: 37521575 Free PMC article.
-
Somatic EPAS1 Variants in Pheochromocytoma and Paraganglioma in Patients With Sickle Cell Disease.J Clin Endocrinol Metab. 2023 Nov 17;108(12):3302-3310. doi: 10.1210/clinem/dgad311. J Clin Endocrinol Metab. 2023. PMID: 37285480 Free PMC article.
References
-
- Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900. - PubMed
-
- Opotowsky AR, Landzberg MJ, Beghetti M. The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. Heart Fail Clin. 2014;10(1):91–104. - PubMed
-
- Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–1942. - PubMed
-
- Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287(5454):848–851. - PubMed
-
- Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–1466. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
